We have all beleived that aspirin use will lower the risk of heart attack, mostly becuase it thins the blood. The problem I have always foudn though is that too much aspirin will stop the blood from clotting quickly and this in itslef almost led to a quick trip to the hospital for my wife last year.

This new study below though seems to show that it is not so obvious as to wether Aspirin really helps to prevent heart attacks but in itslef it is a good read with lots of findings

Long-term, low-dose aspirin provides no clear net value for primary prevention of cardiovascular events in apparently healthy adults, according to a meta-analysis of patient-level data.

In people not known to have cardiovascular disease, aspirin reduced composite MI, stroke, and vascular death rates to 0.51% per year compared with 0.57% among controls for a relative 12% reduction, according to Colin Baigent, B.M.B.Ch., of the University of Oxford, England, and colleagues in the Antithrombotic Trialists’ Collaboration. Read the rest of this entry »

Looking to make a change and lose some weight? I have reviewed the top diet on the internet and you can go and read over 200 comments people have made about why this diet has worked well for them, as well as some of the problems.

Tags: American Heart Association, cardiovascular disease, Colin Baigent, coronary heart disease, diabetes, heart attack, heart attacks, heart disease, high blood pressure, Michigan, stroke, U.S. Preventive Services Task Force, United Kingdom, University of Oxford

Perhaps Vioxx and Celebrex and the Cox-2 inhibitors are not the culprit. There is an important report from England that is saying that using Ibuprofen as an arthritis pain killer will raise your heart attack risk as much as Vioxx or Celebrex.

High doses of older painkiller drugs may pose the same cardiac risk as newer medications such as
Vioxx and other cox-2 inhibitor drugs, according to a British study that looked at what is regarded as the best evidence from randomized, controlled trials.

Data from 138 such trials with 140,000 participants showed a 42 percent increased risk of serious blood vessel problems such as heart attack and stroke in those taking selective cox-2 inhibitors, the chemical class that includes Vioxx ,
Bextra and Celebrex. Cox-2 inhibitors belong to a broader class of pain relievers called nonsteroidal anti-inflammatory drugs (NSAIDs), which also include non-cox-2 medications such as ibuprofen, diclofenac, naproxen and aspirin.

And the study — which was funded by various U.K. public-sector medical groups — also found a similar increase in cardiac risk for other NSAIDs, said Dr. Colin Baigent, a reader in clinical epidemiology at the University of Oxford and an author of the report in the June 3 issue of the British Medical Journal.

Specifically, long-term use of high-dose (800 milligrams three times per day) ibuprofen was associated with a 51 percent higher risk for “vascular events” compared to placebo, while long-term use of high-dose (75 milligrams two times a day) diclofenac boosted the risk by 63 percent, the U.K. team reported. No such risk was seen with long-term use of naproxen (sold under the brand name Aleve).
Read the rest of this entry »

Tags: Aleve, arthritis, Author, Cataflam, chemical class, Cleveland Clinic, Colin Baigent, Cox, heart attack, heart disease, ibuprofen, interim chairman, Massage, Merck, Merck & Co., Motrin, pain, pain killing products, Steven Nissen, the British Medical Journal, United Kingdom, University of Oxford, vioxx